Breaking News Instant updates and real-time market news.

2020-07-30 10:14:19 CNSL Consolidated Communications $6.96 / +0.905 (+14.95%) 10:14 07/30/20 07/30 10:14 07/30/20 10:14	Consolidated Communications exploring options, Dealreporter says Consolidated Communications has hired Wells Fargo and Morgan Stanley to help it explore strategic alternatives, according to Dealreporter's Jon Berke and Matt O'Brien. A review of strategic options began under the company's capital allocation plan that was announced last year but "the road to finding a buyer has become more difficult" in the last few weeks, the report said, according to contacts. Sources tell Dealreporter that several potential suitors withdrew from negotiations as they determined they were unable to take the entire company private, contacts tell The Fly that the M&A publication said.	30 Jul

2020-07-30 10:14:19

CNSL

Consolidated Communications

$6.96 / +0.905 (+14.95%)

10:14

07/30/20

07/30

10:14

07/30/20

10:14

Consolidated Communications exploring options, Dealreporter says

Consolidated Communications has hired Wells Fargo and Morgan Stanley to help it explore strategic alternatives, according to Dealreporter's Jon Berke and Matt O'Brien. A review of strategic options began under the company's capital allocation plan that was announced last year but "the road to finding a buyer has become more difficult" in the last few weeks, the report said, according to contacts. Sources tell Dealreporter that several potential suitors withdrew from negotiations as they determined they were unable to take the entire company private, contacts tell The Fly that the M&A publication said.

30
Jul

TODAY'S FREE FLY STORIES

Hot Stocks	DZS acquires Optelian, terms not disclosed » 08:08 01/20/21 01/20 08:08 01/20/21 08:08 DZSI DZS $16.98 / -0.03 (-0.18%) DZS announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options DZSI DZS $16.98 / -0.03 (-0.18%) 01/04/21 DZS appoints Matt Bross, Barbara Carbone to board of directors 10/22/20 DZS pulls forward earnings release, conference call 10/06/20 DZS names Andrew Bender as CTO, Darrin Whitney as CIO 09/17/20 Dasan Zhone, Tektraco Telecom collaborate on gigabit-ready hotels and facilities DZSI DZS $16.98 / -0.03 (-0.18%) 01/11/21 B. Riley Securities DZS price target raised to $20 from $15 at B. Riley Securities 01/04/21 Craig-Hallum DZS price target raised to $24 from $18 at Craig-Hallum 11/02/20 B. Riley Securities DZS price target raised to $15 from $14 at B. Riley Securities 07/09/20 B. Riley FBR EXFO results positive for Viavi and Dasan, says B. Riley FBR DZSI DZS $16.98 / -0.03 (-0.18%) 10/29/20 DZS sees Q4 revenue $75M-$80M, consensus $85.61M 10/29/20 DZS reports Q3 EPS 20c, consensus 3c 08/05/20 Dasan Zhone reports Q2 EPS 9c, consensus (14c) DZSI DZS $16.98 / -0.03 (-0.18%) 01/06/21 Fifteen new option listings on January 6th
Initiation	Genius Sports initiated with a Buy at Craig-Hallum » 08:07 01/20/21 01/20 08:07 01/20/21 08:07 DMYD dMY Technology II $16.79 / -0.6501 (-3.73%) Craig-Hallum analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News On The Fly DMYD dMY Technology II $16.79 / -0.6501 (-3.73%) 12/09/20 dMY Technology II rises 15.9% 10/27/20 Genius Sports to become public company through dMY Technology II combination DMYD dMY Technology II $16.79 / -0.6501 (-3.73%) 10/27/20 Fly Intel: Pre-market Movers
Syndicate	Lithium Americas 15.9M share Spot Secondary priced at $22.00 » 08:06 01/20/21 01/20 08:06 01/20/21 08:06 LAC Lithium Americas $26.80 / +6.27 (+30.54%) The deal size was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options LAC Lithium Americas $26.80 / +6.27 (+30.54%) 07:50 Today Lithium Americas trading halted, news pending 01/19/21 Lithium Americas rises 30.6% 01/19/21 Lithium Americas rises 19.6% 01/19/21 Lithium Americas rises 15.7% LAC Lithium Americas $26.80 / +6.27 (+30.54%) 01/06/21 Canaccord Lithium Americas price target raised to C$20 from C$11.50 at Canaccord 12/23/20 Stifel Stifel starts Lithium Americas with Buy, sees 'attractive upside' 12/22/20 Stifel Lithium Americas initiated with a Buy at Stifel 10/21/20 Roth Capital Lithium Americas downgraded to Neutral from Buy at Roth Capital LAC Lithium Americas $26.80 / +6.27 (+30.54%) 08/14/20 Lithium Americas reports Q2 EPS (7c) vs. (7c) last year 20 Jan LAC Lithium Americas $26.80 / +6.27 (+30.54%) 01/19/21 Fly Intel: After-Hours Movers 12/22/20 Fly Intel: After-Hours Movers 09/23/20 Tesla, lithium names under pressure as Wall Street digests Battery Day LAC Lithium Americas $26.80 / +6.27 (+30.54%) 01/13/21 Lithium Americas call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd 12/22/20 Lithium Americas call volume above normal and directionally bullish 12/18/20 Largest borrow rate increases among liquid names
Hot Stocks	Ocular Therapeutix to present new OTX-TIC data at Glaucoma 360 Forum » 08:06 01/20/21 01/20 08:06 01/20/21 08:06 OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) Ocular Therapeutix… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) 12/22/20 Ocular Therapeutix submits Dextenza sNDA to FDA 11/04/20 Ocular Therapeutix receives permanent category I CPT code from AMA 10/30/20 Ocular Therapeutix announces Dextenza, OTX-TIC license agreement with AffaMed 10/13/20 Ocular Therapeutix reaches agreement w/ FDA on ReSure retrospective study OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) 12/30/20 JMP Securities Ocular Therapeutix price target raised to $30 from $20 at JMP Securities 12/28/20 Fly Intel: Top five analyst calls 12/28/20 H.C. Wainwright Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright 12/21/20 Piper Sandler Ocular Therapeutix price target raised to $28 from $16 at Piper Sandler OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) 11/05/20 Ocular Therapeutix reports Q3 EPS (21c), consensus (24c) 10/07/20 Ocular Therapeutix reports preliminary Q3 revenue $5.8M-$5.9M, consensus $3.91M 08/07/20 Ocular Therapeutix reports Q2 EPS (64c), consensus (31c) 16 Dec 14 Oct 20 May OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) 12/28/20 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: Pre-market Movers 12/14/20 Fly Intel: After-Hours Movers 10/13/20 Fly Intel: After-Hours Movers
Earnings	EDAP TMS reports preliminary 2020 revenue EUR41.6M vs. EUR44.9M last year 08:06 01/20/21 01/20 08:06 01/20/21 08:06 EDAP EDAP TMS $6.81 / +0.14 (+2.10%) ShowHide Related Items >><< Company News Street Research Earnings EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 01/14/21 EDAP TMS announces 24 month interim results of AFU sponsored study 01/06/21 EDAP TMS CEO says sales pipeline continues to grow entering 2021 12/30/20 EDAP TMS announces two Focal One sales to healthcare institutions 12/09/20 EDAP TMS announces final U.S. 2021 reimbursement rules for HIFU EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 01/12/21 B. Riley Securities EDAP TMS price target raised to $11.50 from $5.50 at B. Riley Securities 04/15/20 Fly Intel: Top five analyst initiations 04/15/20 B. Riley FBR EDAP TMS initiated with a Buy at B. Riley FBR 04/15/20 B. Riley FBR EDAP TMS initiated with a Buy at B. Riley FBR EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 08:05 Today EDAP TMS reports preliminary Q4 revenue EUR15.3M vs. EUR12M last year 08/26/20 EDAP TMS reports Q2 EPS (EUR0.01) vs. EUR0.05 a year ago

Hot Stocks	CSG names Channing Martin Jones chief diversity, social responsibility officer » 08:05 01/20/21 01/20 08:05 01/20/21 08:05 CSGS CSG $44.40 / +1.2 (+2.78%) CSG announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CSGS CSG $44.40 / +1.2 (+2.78%) 12/01/20 CSG extends partnership with Airtel Africa 11/04/20 CSG expands relationship with Inmarsat 09/29/20 CSG's Forte Payment System in strategic pact with Accela 08/31/20 CSG CEO Bret Griess to step down, Brian Shepherd named CEO CSGS CSG $44.40 / +1.2 (+2.78%) 09/10/20 B. Riley FBR CSG pullback brings attractive entry point, says B. Riley FBR 03/10/20 Sidoti CSG upgraded to Buy from Neutral at Sidoti CSGS CSG $44.40 / +1.2 (+2.78%) 11/04/20 CSG backs FY20 EPS view of $2.87-$3.10, two estimates $3.02 11/04/20 CSG reports Q3 EPS 76c, two estimates 79c 08/05/20 CSG backs FY20 EPS view of $.287-$3.10, consensus $3.05 08/05/20 CSG reports Q2 EPS 59c, consensus 70c 02/03/21 CSG - CSGS
Recommendations	Netflix price target raised to $650 from $610 at Jefferies » 08:05 01/20/21 01/20 08:05 01/20/21 08:05 NFLX Netflix $501.85 / +3.9 (+0.78%) Jefferies analyst Alex… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' NFLX Netflix $501.85 / +3.9 (+0.78%) 08:04 Today Barclays Netflix price target raised to $650 from $550 at Barclays 07:52 Today Monness Crespi Netflix price target raised to $650 from $600 at Monness Crespi 07:31 Today Canaccord Netflix price target raised to $670 from $630 at Canaccord 07:26 Today Deutsche Bank Netflix price target raised to $600 from $580 at Deutsche Bank NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c NFLX Netflix $501.85 / +3.9 (+0.78%) 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Fly Intel: After-Hours Movers 01/19/21 Fly Intel: What to watch in Netflix earnings report 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th 10/21/20 Notable open interest changes for October 21st
Earnings	EDAP TMS reports preliminary Q4 revenue EUR15.3M vs. EUR12M last year » 08:05 01/20/21 01/20 08:05 01/20/21 08:05 EDAP EDAP TMS $6.81 / +0.14 (+2.10%) Marc Oczachowski,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 01/14/21 EDAP TMS announces 24 month interim results of AFU sponsored study 01/06/21 EDAP TMS CEO says sales pipeline continues to grow entering 2021 12/30/20 EDAP TMS announces two Focal One sales to healthcare institutions 12/09/20 EDAP TMS announces final U.S. 2021 reimbursement rules for HIFU EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 01/12/21 B. Riley Securities EDAP TMS price target raised to $11.50 from $5.50 at B. Riley Securities 04/15/20 Fly Intel: Top five analyst initiations 04/15/20 B. Riley FBR EDAP TMS initiated with a Buy at B. Riley FBR 04/15/20 B. Riley FBR EDAP TMS initiated with a Buy at B. Riley FBR EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 08/26/20 EDAP TMS reports Q2 EPS (EUR0.01) vs. EUR0.05 a year ago
Recommendations	Netflix price target raised to $650 from $550 at Barclays » 08:04 01/20/21 01/20 08:04 01/20/21 08:04 NFLX Netflix $501.85 / +3.9 (+0.78%) Barclays analyst Kannan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' NFLX Netflix $501.85 / +3.9 (+0.78%) 07:52 Today Monness Crespi Netflix price target raised to $650 from $600 at Monness Crespi 07:31 Today Canaccord Netflix price target raised to $670 from $630 at Canaccord 07:26 Today Deutsche Bank Netflix price target raised to $600 from $580 at Deutsche Bank 07:23 Today Cowen Netflix price target raised to $675 from $650 at Cowen NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c NFLX Netflix $501.85 / +3.9 (+0.78%) 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Fly Intel: After-Hours Movers 01/19/21 Fly Intel: What to watch in Netflix earnings report 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th 10/21/20 Notable open interest changes for October 21st
Hot Stocks	Clarivate Analytics changing ticker symbol to "CLVT" February 1 » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 CCC Clarivate Analytics $29.28 / -0.135 (-0.46%) Clarivate's ticker… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events CCC Clarivate Analytics $29.28 / -0.135 (-0.46%) 11/30/20 Clarivate Analytics acquires Hanlim IPS 11/09/20 Clarivate Analytics divests Techstreet to ASME 09/01/20 Clarivate Analytics enters partnership with IP DESK 08/27/20 Clarivate Analytics appoints Stefano Maestri as Chief Technology Officer CCC Clarivate Analytics $29.28 / -0.135 (-0.46%) 10/15/20 Goldman Sachs Clarivate Analytics reinstated with a Buy at Goldman Sachs 10/14/20 Morgan Stanley Clarivate Analytics initiated with an Equal Weight at Morgan Stanley 10/02/20 Barclays Clarivate Analytics price target raised to $35 from $26 at Barclays 08/04/20 Citi Clarivate Analytics price target raised to $33 from $28 at Citi CCC Clarivate Analytics $29.28 / -0.135 (-0.46%) 11/25/20 Clarivate Analytics raises 2020 adjusted EPS view to 55c-61c from 53c-59c 11/25/20 Clarivate Analytics sees 2021 adjusted EPS 73c-79c, consensus 78c 10/29/20 Clarivate Analytics raises FY20 adj. EPS view to 55c-61c from 53c-59c 10/29/20 Clarivate Analytics reports Q3 adj. EPS 14c, consensus 15c 04 Jun 06 Feb 02/25/21 Clarivate Analytics - CCC

Downgrade	Healthcare Trust downgraded to Equalweight from Overweight at Capital One » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 HTA Healthcare Trust $28.21 / -0.365 (-1.28%) Capital One downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings HTA Healthcare Trust $28.21 / -0.365 (-1.28%) 01/12/21 Healthcare Trust reports acquisition of $129M of medical office investments 09/22/20 Healthcare Trust reactivates share repurchase program HTA Healthcare Trust $28.21 / -0.365 (-1.28%) 01/13/21 Jefferies Healthcare Trust price target raised to $35 from $33 at Jefferies 01/13/21 Jefferies Healthcare Realty Trust upgraded to Buy with sector 'unscathed' at Jefferies 12/21/20 JPMorgan JPMorgan changes ratings in REIT, Real Estate Services sectors into 2021 12/21/20 JPMorgan Healthcare Trust downgraded to Neutral from Overweight at JPMorgan HTA Healthcare Trust $28.21 / -0.365 (-1.28%) 11/03/20 Healthcare Trust reports Q3 normalized FFO 43c, consensus 42c 08/06/20 Healthcare Trust reports Q2 normalized FFO 42c, consensus 42c
Recommendations	Goldman Sachs price target raised to $335 from $320 at Wells Fargo » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 GS Goldman Sachs $294.20 / -6.85 (-2.28%) Wells Fargo analyst Mike… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/19/21 Goldman Sachs: Investment banking backlog at near-record levels 01/19/21 Goldman Sachs evaluating whether more staff can be moved to strategic locations 01/19/21 Goldman Sachs plans to resume share repurchases this quarter 01/19/21 Goldman Sachs plans to accelerate pace of asset sales GS Goldman Sachs $294.20 / -6.85 (-2.28%) 07:37 Today Oppenheimer Goldman Sachs price target raised to $445 from $407 at Oppenheimer 07:15 Today BMO Capital Goldman Sachs price target raised to $330 from $307 at BMO Capital 06:35 Today RBC Capital Goldman Sachs price target raised to $319 from $225 at RBC Capital 01/12/21 JMP Securities Goldman Sachs price target raised to $320 from $285 at JMP Securities GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/19/21 Goldman Sachs reports Q4 EPS $12.08, consensus $7.47 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports 10/14/20 Goldman Sachs reports Q3 EPS $9.68, consensus $5.57 10/13/20 Notable companies reporting before tomorrow's open GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/07/21 Goldman Sachs CEO: 'I'd be cautious' of stock market volatility, Axios reports 12/31/20 M&A activity rebounded into year-end to finish 2020 down just 5%, FT says 12/29/20 Toshiba holds emergency board meeting amid investor demands, FT reports 12/28/20 Goldman Sachs leads $65M financing in Echelon Fitness, Bloomberg says GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Pre-market Movers 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 02/11/21 Technology & Internet Virtual Conference 02/24/21 22nd Annual Virtual Financial Services Forum 03/25/21 REITwise 2021 Virtual Conference GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/13/21 Unusual call flow in option market yesterday 01/12/21 Short term 300 strike calls in Goldman Sachs see early action 01/07/21 Goldman Sachs call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd
Hot Stocks	Seneca Biopharma reports data from Phase 2 study of NSI-566 in China » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 SNCA Seneca Biopharma $1.34 / + (+0.00%) Seneca Biopharma… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News SNCA Seneca Biopharma $1.34 / + (+0.00%) 01/13/21 Leading BioSciences announces Fast Track Designation for LB1148 01/08/21 Leading BioSciences announces topline data from gastrointestinal surgery study 12/17/20 Seneca Biopharma trading resumes 12/17/20 Seneca Biopharma, Leading BioSciences to merge in all-stock transaction
Hot Stocks	Gritstone, Genevant announce license agreement for COVID-19 vaccine » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 GRTS Gritstone Oncology $22.47 / +16.07 (+251.09%) Gritstone Oncology and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings GRTS Gritstone Oncology $22.47 / +16.07 (+251.09%) 01/19/21 Gritstone Oncology signs agreement with NIAID to begin testing COVID-19 vaccine 01/04/21 EcoR1 Capital reports 9.99% passive stake in Gritstone Oncology 12/28/20 Gritstone Oncology announces private placement financings totaling $125M 12/23/20 Gritstone Oncology announces $110M private placement GRTS Gritstone Oncology $22.47 / +16.07 (+251.09%) 06:25 Today H.C. Wainwright Gritstone Oncology price target raised to $24 from $16 at H.C. Wainwright 05:31 Today Baird Gritstone Oncology downgraded to Underperform from Outperform at Baird 07/14/20 BTIG Gritstone Oncology price target lowered to $17 from $31 at BTIG GRTS Gritstone Oncology $22.47 / +16.07 (+251.09%) 11/05/20 Gritstone Oncology reports Q3 EPS (69c), consensus (64c) 08/05/20 Gritstone Oncology reports Q2 EPS (69c), consensus (73c)
Hot Stocks	F-star Therapeutics receives european patent for FS118 molecule » 08:02 01/20/21 01/20 08:02 01/20/21 08:02 FSTX F-star Therapeutics $9.20 / +0.25 (+2.79%) F-star Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research FSTX F-star Therapeutics $9.20 / +0.25 (+2.79%) 01/04/21 F-star Therapeutics doses first patient in FS222 Phase 1 trial 12/03/20 F-star Therapeutics doses first patient in Phase 1 clinical trial of FS120 11/30/20 Glaxosmithkine reports 8.9% passive stake in F-star Therapeutics FSTX F-star Therapeutics $9.20 / +0.25 (+2.79%) 12/02/20 Ladenburg F-star Therapeutics initiated with a Buy at Ladenburg

Recommendations	Advanced Drainage price target raised to $98 from $89 at Barclays » 08:00 01/20/21 01/20 08:00 01/20/21 08:00 WMS Advanced Drainage $89.44 / +0.15 (+0.17%) Barclays analyst Matthew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events WMS Advanced Drainage $89.44 / +0.15 (+0.17%) 08/06/20 Advanced Drainage sees FY21 CapEx $60M-$65M WMS Advanced Drainage $89.44 / +0.15 (+0.17%) 12/18/20 Barclays Advanced Drainage price target raised to $89 from $77 at Barclays 12/16/20 Loop Capital Advanced Drainage price target raised to $88 from $75 at Loop Capital 10/12/20 Barclays Advanced Drainage price target raised to $77 from $64 at Barclays 10/07/20 Loop Capital Advanced Drainage price target raised to $75 from $67 at Loop Capital WMS Advanced Drainage $89.44 / +0.15 (+0.17%) 11/05/20 Advanced Drainage sees FY21 revenue $1.79B-$1.84B, consensus $1.82B 11/05/20 Advanced Drainage reports Q2 EPS 93c, consensus $1.05 08/06/20 Advanced Drainage reports Q1 EPS 83c, consensus 68c 11 Dec 02/04/21 Advanced Drainage - WMS
Downgrade	Redfin downgraded to Neutral from Buy at DA Davidson » 08:00 01/20/21 01/20 08:00 01/20/21 08:00 RDFN Redfin $76.64 / -0.08 (-0.10%) DA Davidson analyst Tom… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options RDFN Redfin $76.64 / -0.08 (-0.10%) 01/06/21 Redfin expands RedfinNow to Phoenix 10/13/20 Redfin reports U.S. luxury home sales increased 41.5% in Q3 09/11/20 Redfin says U.S. median home sale prices up 13% from last year 08/14/20 Tiger Global takes stake in ZoomInfo during Q2, exits iQIYI RDFN Redfin $76.64 / -0.08 (-0.10%) 01/19/21 Truist Truist keeps Buys on Redfin, Zillow into 'strong' 2021 housing start 01/12/21 BTIG Redfin downgraded to Neutral from Buy at BTIG, prefers Zillow Group 01/12/21 BTIG Redfin downgraded to Neutral from Buy at BTIG 01/06/21 Wedbush Redfin price target raised to $86 from $59 at Wedbush RDFN Redfin $76.64 / -0.08 (-0.10%) 11/06/20 Redfin reported Q3 EPS 30c, consensus 25c 11/05/20 Redfin sees Q4 revenue $226M-$233M, consensus $214.94M 11/05/20 Notable companies reporting after market close 10/15/20 Redfin sees Q3 revenue $235.0M, consensus $222.7M RDFN Redfin $76.64 / -0.08 (-0.10%) 08/13/20 Cost of mortgage refinancing 'about to go up,' NY Times reports RDFN Redfin $76.64 / -0.08 (-0.10%) 01/12/21 NIO downgrade, Wells Fargo upgrade among today's top calls on Wall Street 12/21/20 Microsoft, Walmart upgrades among today's top calls on Wall Street 11/05/20 Fly Intel: After-Hours Movers 09/25/20 Cruise Line upgrades among today's top calls on Wall Street RDFN Redfin $76.64 / -0.08 (-0.10%) 12/28/20 Redfin put volume heavy and directionally bearish 12/09/20 Redfin call volume above normal and directionally bullish 10/15/20 Redfin put volume heavy and directionally bearish 09/24/20 Redfin put volume heavy and directionally bearish
Options	Micron call buyer realizes 56% same-day gains » 08:00 01/20/21 01/20 08:00 01/20/21 08:00 MU Micron $85.49 / +4.76 (+5.90%) Notable profits for the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MU Micron $85.49 / +4.76 (+5.90%) 01/14/21 Micron director sells 50K shares of common stock 01/13/21 Micron's Arnzen sells 15,000 common shares 01/08/21 Micron CEO: We are in the sweet spot of market trends 01/07/21 Micron says data center revenue declined sequentially in Q1 MU Micron $85.49 / +4.76 (+5.90%) 01/19/21 Mizuho Micron not impacted by Xiaomi blacklist, says Mizuho 01/11/21 Citi December notebook shipments good news for Micron and Intel, says Citi 01/08/21 JPMorgan Micron price target raised to $100 from $85 at JPMorgan 01/08/21 Wells Fargo Wells Fargo says Micron remains 2021 Top Pick after Q1 report MU Micron $85.49 / +4.76 (+5.90%) 01/07/21 Micron sees Q2 EPS 75c +/- 7c, consensus 63c 01/07/21 Micron reports Q1 EPS 78c, consensus 71c 01/07/21 Notable companies reporting after market close 12/01/20 Micron raises Q1 adj. EPS view 69c-73c from 40c-54c, consensus 48c MU Micron $85.49 / +4.76 (+5.90%) 12/04/20 Micron fab power outage may impact global DRAM supply, DigiTimes reports 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says MU Micron $85.49 / +4.76 (+5.90%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 01/07/21 Fly Intel: After-Hours Movers 01/07/21 Fly Intel: What to watch in Micron's earnings report 02/11/21 Technology & Internet Virtual Conference MU Micron $85.49 / +4.76 (+5.90%) 01/07/21 Micron options imply 9.7% move in share price post-earnings 01/05/21 Micron call volume above normal and directionally bullish 01/05/21 Early notable gainers among liquid option names on January 5th 01/05/21 Unusually active option classes on open January 5th
Earnings	BOK Financial reports Q4 EPS $2.21, consensus $1.92 » 07:59 01/20/21 01/20 07:59 01/20/21 07:59 BOKF BOK Financial $80.44 / +1.37 (+1.73%) The company's common… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events BOKF BOK Financial $80.44 / +1.37 (+1.73%) 01/04/21 Wells Fargo BOK Financial upgraded to Overweight from Equal Weight at Wells Fargo 10/26/20 Truist BOK Financial price target raised to $69 from $60 at Truist 10/22/20 RBC Capital BOK Financial price target raised to $66 from $60 at RBC Capital 03/09/20 Raymond James BOK Financial downgraded at Raymond James as oil prices sink BOKF BOK Financial $80.44 / +1.37 (+1.73%) 10/21/20 BOK Financial reports Q3 EPS $2.19, consensus $1.56 07/22/20 BOK Financial reports Q2 EPS 92c, consensus $1.12 02/02/21 Texas Bank Virtual Investor Trip 03/11/21 Virtual Atlanta and Texas Bank Summit 10:00 Today BOK Financial - BOKF
Initiation	Nidec initiated with a Buy at Jefferies » 07:59 01/20/21 01/20 07:59 01/20/21 07:59 NJDCY Nidec $0.00 / + (+0.00%) Jefferies analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News NJDCY Nidec $0.00 / + (+0.00%) 01/19/21 Nidec files patent infringement suit against Seagate

Recommendations	Arch Resources price target raised to $72 from $68 at B. Riley Securities » 07:58 01/20/21 01/20 07:58 01/20/21 07:58 ARCH Arch Resources $52.09 / +1.6 (+3.17%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ARCH Arch Resources $52.09 / +1.6 (+3.17%) 10/22/20 Arch Resources announces strategic plan for legacy thermal assets 09/02/20 Ramaco Resources appoints Barkley Sturgill as general counsel ARCH Arch Resources $52.09 / +1.6 (+3.17%) 01/15/21 B. Riley Securities Arch Resources price target raised to $68 from $66 at B. Riley Securities 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 06/30/20 B. Riley FBR Arch Resources price target lowered to $67 from $73 at B. Riley FBR 04/27/20 Jefferies Jefferies sees coal mining equities lagging, cuts ratings on three miners ARCH Arch Resources $52.09 / +1.6 (+3.17%) 10/22/20 Arch Resources reports Q3 EPS ($12.64), consensus ($1.04) 07/28/20 Arch Resources reports Q2 EPS ($3.26), consensus ($2.55)
Recommendations	Freeport McMoRan price target raised to $32 from $30 at B. Riley Securities » 07:58 01/20/21 01/20 07:58 01/20/21 07:58 FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 10/22/20 Freeport McMoRan: Makes more sense to develop mines than buy assets 10/22/20 Freeport McMoRan will be 'comfortable' when net debt falls to $5B 10/22/20 Freeport 'confident' in ability to recommend restored dividend in 2021 10/22/20 Freeport McMoRan: No decision yet on new smelter plan in Indonesia FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 01/13/21 Deutsche Bank Freeport McMoRan price target raised to $33 from $20 at Deutsche Bank 01/05/21 Fly Intel: Top five analyst upgrades 01/05/21 B. Riley Securities Freeport McMoRan price target raised to $30 from $26 at B. Riley Securities 01/05/21 Argus upgrades Freeport McMoRan to Buy on recovery in manufacturing and metals FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 10/22/20 Freeport McMoRan reports Q3 EPS 22c, consensus 21c 10/21/20 Notable companies reporting before tomorrow's open 10/21/20 Notable companies reporting before tomorrow's open 07/23/20 Freeport McMoRan reports Q2 EPS 3c, consensus (2c) FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 09/16/20 CFO says Freeport not wanting to be 'distracted' by buyout bids, Reuters reports 08/24/20 Workers bar access to Freeport Indonesia's Grasberg mine, Reuters reports FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 11/11/20 Fly Intel: After-Hours Movers 01/26/21 Freeport McMoRan - FCX FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 01/07/21 Early notable gainers among liquid option names on January 7th 01/04/21 Early notable gainers among liquid option names on January 4th 12/31/20 Unusually active option classes on open December 31st 12/30/20 Freeport McMoRan call volume above normal and directionally bullish
Initiation	Sapiens initiated with a Buy at Jefferies » 07:58 01/20/21 01/20 07:58 01/20/21 07:58 SPNS Sapiens $31.51 / +0.49 (+1.58%) Jefferies analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly SPNS Sapiens $31.51 / +0.49 (+1.58%) 12/16/20 Sapiens partners with TruthMD for advanced data analytics 11/09/20 Sapiens acquires Tia Technology, terms not disclosed 09/24/20 Sapiens partners with GreenRoad Technologies for auto insurance solution 09/08/20 Sapiens appoints Jeannine Sargent to its board of director SPNS Sapiens $31.51 / +0.49 (+1.58%) 01/13/21 Fly Intel: Top five analyst initiations 01/13/21 Goldman Sachs Sapiens initiated with a Neutral at Goldman Sachs 12/22/20 Fly Intel: Top five analyst initiations 12/22/20 Citi Sapiens initiated with a Buy at Citi SPNS Sapiens $31.51 / +0.49 (+1.58%) 08/04/20 Sapiens raises FY20 revenue view to $376M-$381M from $368M-$377M 08/04/20 Sapiens reports Q2 EPS 26c, consensus 21c 16 Oct SPNS Sapiens $31.51 / +0.49 (+1.58%) 10/13/20 Fly Intel: After-Hours Movers
Recommendations	Comerica price target raised to $72 from $65 at B. Riley Securities » 07:57 01/20/21 01/20 07:57 01/20/21 07:57 CMA Comerica $63.85 / +0.16 (+0.25%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options CMA Comerica $63.85 / +0.16 (+0.25%) 08/19/20 Comerica partners with Minority Depository Institutions 07/21/20 Comerica up 4.8% after reporting Q2 results CMA Comerica $63.85 / +0.16 (+0.25%) 01/14/21 Raymond James Comerica upgraded to Outperform from Market Perform at Raymond James 01/14/21 Raymond James Comerica upgraded to Outperform from Market Perform at Raymond James 01/13/21 Baird Comerica downgraded to Neutral following rally at Baird 01/13/21 Baird Comerica downgraded to Neutral from Outperform at Baird CMA Comerica $63.85 / +0.16 (+0.25%) 01/19/21 Comerica reports Q4 EPS $1.49, consensus $1.19 10/20/20 Comerica reports Q3 EPS $1.44, consensus 83c 07/21/20 Comerica reports Q2 EPS 80c, consensus 21c 02/02/21 Texas Bank Virtual Investor Trip 03/11/21 Virtual Atlanta and Texas Bank Summit 04/20/21 Comerica - CMA CMA Comerica $63.85 / +0.16 (+0.25%) 10/20/20 Early notable gainers among liquid option names on October 20th
Recommendations	Zions Bancorp price target raised to $57 from $55 at B. Riley Securities » 07:56 01/20/21 01/20 07:56 01/20/21 07:56 ZION Zions Bancorp $49.35 / +0.19 (+0.39%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events Options ZION Zions Bancorp $49.35 / +0.19 (+0.39%) 01/07/21 B. Riley Securities Zions Bancorp price target raised to $55 from $52 at B. Riley Securities 01/04/21 Barclays Zions Bancorp downgraded to Equal Weight with $50 target at Barclays 01/04/21 Barclays Zions Bancorp downgraded to Equal Weight from Overweight at Barclays 12/07/20 Evercore ISI Zions Bancorp upgraded to Outperform from In Line at Evercore ISI ZION Zions Bancorp $49.35 / +0.19 (+0.39%) 01/19/21 Zions Bancorp reports Q4 EPS $1.66, consensus $1.02 01/19/21 Notable companies reporting after market close 10/19/20 Zions Bancorp reports Q3 EPS $1.01, consensus 88c 07/20/20 Zions Bancorp reports Q2 EPS 34c, consensus 38c ZION Zions Bancorp $49.35 / +0.19 (+0.39%) 01/19/21 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: After-Hours Movers 04/19/21 Zions Bancorp - ZION ZION Zions Bancorp $49.35 / +0.19 (+0.39%) 01/19/21 Zions Bancorp options imply 4.3% move in share price post-earnings

Events

Earnings calls, analyst events, roadshows and more

FNB
Today at 08:15

F.N.B. - FNB Conference Calls
MS
Today at 08:30

Morgan Stanley - MS Conference Calls
PG
Today at 08:30

Procter & Gamble - PG Conference Calls
UNH
Today at 08:45

UnitedHealth - UNH Conference Calls
Today at 08:55

Redbook Store Sales Y/Y: 1/16/21 Government Event
USB
Today at 09:00

U.S. Bancorp - USB Conference Calls
PNFP
Today at 09:30

Pinnacle Financial - PNFP Conference Calls
NJR
Today at 09:30

New Jersey Resources Corp Firm Sponsored Meetings
Today at 10:00

Housing Market Index: January 2021 Government Event
BOKF
Today at 10:00

BOK Financial - BOKF Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright $17.00-18.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald $1.90-2.00 CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $64.18 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE $13.96 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares
Fri	No deals

View All Syndicate Announcements »

Consolidated Communications exploring options, Dealreporter says

TODAY'S FREE FLY STORIES

Get Full Fly Access